Clinical trial
Infections and Autoimmunity: Autobodies Screening in Multiple Sclerosis
NCT00230204 · Sheba Medical Center, Other · Unknown status
Key facts
| NCT number | NCT00230204 |
|---|---|
| Title | Infections and Autoimmunity: Autobodies Screening in Multiple Sclerosis |
| Official title | Antibodies Screening in Multiple Sclerosis as a Part of an International Survey in Autoimmune Diseases. |
| Lead sponsor | Sheba Medical Center, Other |
| Status | Unknown status |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Multiple Sclerosis |
| Intervention type | Procedure |
| Interventions | Serum antibodies to infectious agents using the BioPlex 2200 and complementary EIA kits |
| Enrollment | 100 |
| Start date | Sep 1, 2005 |
| Completion | Apr 1, 2006 |
| First posted | Sep 30, 2005 |
| Last update posted | Feb 16, 2006 |
| Countries | Israel |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: